Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT04826458
Eligibility Criteria:
Inclusion Criteria:
* ≥ 18 years old (both genders)
* Eastern Cooperative Oncology Group (ECOG) ≤2
* Patients with solid and haematological neoplasia (adjuvant or advanced setting) candidates to treatment with oral therapy.
Exclusion Criteria:
* Patients who also receive anticancer treatment intravenously, as such patients access the hospital regularly and are in closer contact with healthcare personnel.
* Patients receiving experimental cancer treatment
* Patients who are unable to cooperate with study procedures (in the researcher's opinion)
* Patients who are candidates for oral drug treatment lasting less than 3 months.
* Patients with a life expectancy \<12 weeks.
* All patients being treated with drugs not listed in the Protocol Appendix C.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04826458
Study Brief:
Protocol Section:
NCT04826458